Nottinghamshire Pharmacy Faces Closure Amid Rising Costs and Funding Shortfalls

The proprietor of a pharmacy, which has been under family ownership for four decades, expresses apprehension that the business might cease operations. This concern arises from escalating medication expenses and insufficient funding from the NHS. Gurminder Singh, 35, inherited Singh Pharmacy, situated in West Bridgford, Nottinghamshire, from his father, Shamser Singh, aged 63. Gurminder indicates that the pharmacy is currently incurring monthly losses in the thousands of pounds and is “barely surviving” due to “significant losses” on certain NHS medicines it supplies to patients. The Department of Health and Social Care (DHSC) stated that it inherited a system that had been “neglected” for an extended period and committed to developing a service “fit for the future.” Shamser Singh had attended to patients since the pharmacy’s establishment in 1984. Gurminder, a qualified pharmacist, assumed control three years ago, and a second branch commenced operations in the Lady Bay area in 2022. Gurminder remarked: “My whole reason for choosing pharmacy as a career was because of this family legacy.” He added: “We’re a part of the community here.” Gurminder asserts that managing the family business is “completely different” compared to when his father was in charge, as the enterprise is now “crippled” by the cost of specific medications not consistently covered by the NHS. Gurminder reports that his pharmacy is losing thousands of pounds per month, and over the past six months, he has personally expended approximately £20,000 to meet the business’s overheads. “If nothing changes, we can only continue to operate for the next three to six months,” he added. He further stated: “A lot of our customers are older, and as their living costs are increasing, we didn’t want to make things harder for them.” Gurminder continued: “There aren’t enough hours in the day to oversee the business and do the private services that help to keep us afloat.” He concluded: “Honestly… [the pharmacy] is barely surviving. It is disheartening for me and my parents.” Community Pharmacy England reported that the sector had experienced a 30% funding reduction, and that 60% of local pharmacy leaders anticipate an increase in permanent closures of local pharmacies this winter. Chief executive Janet Morrison added: “If [pharmacies] are left to collapse, the impact on businesses and their staff, on patients, on the wider NHS, and ultimately on the nation’s health, will be unthinkable.” For every medicine, pharmacies receive reimbursement at a price agreed upon under the NHS contract. They can generate profit if they acquire the drugs at a cost lower than the price the NHS provides them. One medication on which Singh Pharmacy is incurring losses is memantine, a tablet utilized to treat memory loss and frequently prescribed to individuals exhibiting signs of dementia. Gurminder states that it costs the pharmacy £12 to purchase, but the price established by the NHS is approximately £7.99, resulting in a loss of about £4 on each packet sold. Gurminder said: “Patient care is a priority for us, and so we have no choice but to sell this medication at a loss.” He added: “We only get a £1 dispensing fee each time we sell that, and that’s supposed to go towards staff wages and running costs.” Joy Edwards, a dispenser at Singh Pharmacy for four years, informed the BBC that her primary concern is how a potential closure would affect elderly patients. She stated: “There are a lot of elderly people in this area, and if we close, what happens to them?” She concluded: “We don’t know what the future holds, but know that pharmacies need more funding to make sure they can keep going.” Serine Hamada, 27, a trainee pharmacist at the establishment, commented: “Graduating into a time where the future of pharmacies is uncertain is scary. “You see lots of pharmacies shutting, but us graduates want to get out and work.” She added: “I am nervous about the future.” The BBC has sought a statement from NHS England.